Danish Cardiogenic Shock Trial

NACompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

July 31, 2023

Study Completion Date

April 30, 2024

Conditions
Cardiogenic Shock AcuteAcute Myocardial Infarction
Interventions
DEVICE

Conventional circulatory support

Control group treated with conventional circulatory support and observed in intensive care unit for a minimum of 48 hrs.

DEVICE

Impella CP

Control group treated with Impella CP for a minimum of 48 hrs.

Trial Locations (13)

2100

Copenhagen University Hospital Rigshospitalet, Copenhagen

8200

Aarhus University Hospital Skejby, Aarhus

DK-5000

Odense University Hospital, Odense

Unknown

Charite Berlin, Berlin

University Hospital Bonn, Bonn

Dresden University Hospital, Dresden

Düsseldorf University Hospital, Düsseldorf

UKE Hamburg, Hamburg

Hannover Medical School, Hanover

Jena University Hospital, Jena

Brüderkrankenhaus Trier, Trier

University Hospital Würzburg, Würzburg

NHs Harefield Hospital, London

All Listed Sponsors
collaborator

Aarhus University Hospital Skejby

OTHER

collaborator

Hannover Medical School

OTHER

collaborator

University Hospital, Bonn

OTHER

collaborator

Jena University Hospital

OTHER

collaborator

University Hospital Dresden

OTHER

collaborator

Heinrich-Heine University, Duesseldorf

OTHER

collaborator

Universitätsklinikum Hamburg-Eppendorf

OTHER

collaborator

Charite University, Berlin, Germany

OTHER

collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

collaborator

Wuerzburg University Hospital

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

lead

Odense University Hospital

OTHER

NCT01633502 - Danish Cardiogenic Shock Trial | Biotech Hunter | Biotech Hunter